Recent trends in medicinal plants research /
Plants and other living organisms have great potential to treat human disease. There are two distinct types of biomedical research that seek to develop this potential. One type of research explores the value of medicinal plants as traditionally used and studies of these plants have the potential to...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Oxford :
Academic,
2012.
|
Colección: | Advances in botanical research ;
v. 62. |
Temas: | |
Acceso en línea: | Texto completo Texto completo |
Tabla de Contenidos:
- Front Cover; Recent Trends in Medicinal Plants Research; Copyright; Contents; Contributors to Volume 62; Preface; Contents of Volumes 35-61; Chapter 1: Authentication and Quality Assessment of the Antitussive Herb Baibu (Radix Stemonae); I. Introduction; II. Species Specification and Authentication; A. Source Plants of Radix Stemonae; 1. Stemona japonica; 2. Stemona sessilifolia; 3. Stemona tuberosa; B. Pharmacognostic Differentiation of Radix Stemonae; C. Substitutes from Asparagus Species; 1. Pharmacognostic differences; III. Stemona Alkaloids; A. Chemical Diversity in S. tuberosa
- B. Chemical Diversity Among Stemona SpeciesC. Antitussive Components; D. Antitussive Pathways and Mechanisms of Action; E. Adverse Reactions; IV. Quality Assessment; V. Conclusions; References; Chapter 2: In Vitro Propagation and Approaches for Metabolites Production in Medicinal Plants; I. Introduction; II. In Vitro Propagation of Medicinal Plants; A. Pinellia ternate; B. Momordica charantia; C. Gentiana scabra var Bunge; D. Taraxacum formosanum; III. Production of Secondary Metabolites; A. In Vitro Production of Fangochinoline and Tetrandrine from S. tetrandra
- B. Enhanced Tanshinone Production in Hairy Roots of `S. miltiorrhiza Bunge� C. Gentiopicroside and Swertiamarin Production from G. davidii var. formosana (Hayata); D. Diosgenin Production from the Cell Suspension Culture of D. doryophora Hance; References; Chapter 3: Regulation of Inflammation-Mediated Chronic Diseases by Botanicals; I. Introduction; II. Transcription Factors as Mediators of Chronic Diseases; A. Nuclear Factor-kappaB; B. Activator Protein-1; C. Signal Transducer and Activator of Transcription-3; D. beta-Catenin/Wnt; E. Hypoxia Inducible Factor-1
- F. Nuclear Factor Erythroid 2-Related FactorG. Peroxisome Proliferator-Activated Receptor; H. Hedgehog; I. Heat Shock Protein 90; III. Role of Botanicals Against Chronic Diseases; A. Role of Chalcones Against Chronic Diseases; 1. Butein; 2. Cardamonin; 3. Xanthohumol; B. Role of Flavonoids Against Chronic Diseases; 1. Fisetin; 2. Deguelin; 3. Gossypin; 4. Morin; C. Role of Alkaloids Against Chronic Diseases; 1. Berberine; 2. Evodiamine; 3. Noscapine; 4. Sanguinarine; 5. Indirubin; D. Role of Xanthones Against Chronic Diseases; 1. gamma-Mangostin; 2. Mangiferin; 3. Gambogic acid
- E. Role of Triterpenoids Against Chronic Diseases1. Betulinic acid; 2. Celastrol; 3. Ursolic acid; 4. Pristimerin; 5. Acetyl-11-keto-beta-boswellic acid; 6. Diosgenin; 7. Escin; F. Role of Chavicols Against Chronic Diseaeses; 1. Eugenol; 2. Hydroxychavicol; 3. 1-Acetoxychavicol acetate; G. Role of Quinones Against Chronic Diseases; 1. Thymoquinone; 2. Embelin; 3. Capsaicin; 4. Plumbagin; 5. Emodin; H. Role of Polyphenols Against Chronic Diseases; 1. Curcumin; 2. Tocotrienol; IV. Conclusions; References; Chapter 4: Taxol, Camptothecin and Beyond for Cancer Therapy; I. Introduction